Seth Rotberg joins the podcast to talk through the in’s and out’s of patient advocacy, the patient’s role in drug development, and how patients can work with regulators to make sure the best possible medications reach approval. Since Gunnar considers himself a patient advocate, too, they are able to talk about their frustrations with the role, but more important the impact they think patient advocates can have inside the health industry. Seth talks to Gunnar about the frustration that some drug developers have had with taking on Huntington’s Disease, while Seth also shares that he has some frustration with how drugs are evaluated for efficacy in Huntington’s Disease clinical trials.

Subscribe to the State of Health on Spotify and iTunes!